Skip to main content
Back to main menu

About Us

How we work

See what triggers an intervention and how supply and logistics allow our teams to respond quickly.

Learn more
How we're run

Discover our governance and what it means to be an association. Find a quick visual guide to our offices around the world.

Learn more
Reports and financials

Read through our annual financial and activity reports, and find out about where our funds come from and how they are spent.

Learn more
Accountability

Read the policies, reports, and plans on how we address issues like racism and reduce our carbon footprint, ensuring our actions align with the highest ethical standards.

Learn more

What we do

Médecins Sans Frontières brings medical humanitarian assistance to victims of conflict, natural disasters, epidemics or healthcare exclusion.

View all topics Activities by country
Featured Gaza Israel war Conflict in Sudan Surgery & trauma care

Where we work

In more than 70 countries, Médecins Sans Frontières provides medical humanitarian assistance to save lives and ease the suffering of people in crisis situations.

View all countries
Featured Palestine Sudan South Sudan

MSF Websites

A Global Network
Our offices around the world
Our offices around the world
Other Sites
View Resource Centre
Access Campaign

We set up the MSF Access Campaign in 1999 to push for access to, and the development of, life-saving and life-prolonging medicines, diagnostic tests and vaccines for people in our programmes and beyond.

GO TO SITE
CRASH

Based in Paris, CRASH conducts and directs studies and analysis of MSF actions. They participate in internal training sessions and assessment missions in the field.

GO TO SITE
UREPH

Based in Geneva, UREPH (or Research Unit) aims to improve the way MSF projects are implemented in the field and to participate in critical thinking on humanitarian and medical action.

GO TO SITE
ARHP

Based in Barcelona, ARHP documents and reflects on the operational challenges and dilemmas faced by the MSF field teams.

GO TO SITE
MSF Analysis

Based in Brussels, MSF Analysis intends to stimulate reflection and debate on humanitarian topics organised around the themes of migration, refugees, aid access, health policy and the environment in which aid operates.

GO TO SITE
MSF Supply

This logistical and supply centre in Brussels provides storage of and delivers medical equipment, logistics and drugs for international purchases for MSF missions.

GO TO SITE
MSF Logistique

This supply and logistics centre in Bordeaux, France, provides warehousing and delivery of medical equipment, logistics and drugs for international purchases for MSF missions.

GO TO SITE
Amsterdam Procurement Unit

This logistical centre in Amsterdam purchases, tests, and stores equipment including vehicles, communications material, power supplies, water-processing facilities and nutritional supplements.

GO TO SITE
Brazilian Medical Unit

BRAMU specialises in neglected tropical diseases, such as dengue and Chagas, and other infectious diseases. This medical unit is based in Rio de Janeiro, Brazil.

GO TO SITE
MSF Medical Guidelines

Our medical guidelines are based on scientific data collected from MSF’s experiences, the World Health Organization (WHO), other renowned international medical institutions, and medical and scientific journals.

GO TO SITE
Epicentre

Providing epidemiological expertise to underpin our operations, conducting research and training to support our goal of providing medical aid in areas where people are affected by conflict, epidemics, disasters, or excluded from health care.

GO TO SITE
Evaluation Units

Evaluation Units have been established in Vienna, Stockholm, and Paris, assessing the potential and limitations of medical humanitarian action, thereby enhancing the effectiveness of our medical humanitarian work.

GO TO SITE
LGBTQI+ Inclusion in Health Settings

MSF works with LGBTQI+ populations in many settings over the last 25-30 years. LGBTQI+ people face healthcare disparities with limited access to care and higher disease rates than the general population.

GO TO SITE
LUXOR

The Luxembourg Operational Research (LuxOR) unit coordinates field research projects and operational research training, and provides support for documentation activities and routine data collection.

GO TO SITE
MSF Academy for Healthcare

To upskill and provide training to locally-hired MSF staff in several countries, MSF has created the MSF Academy for Healthcare.

GO TO SITE
Humanitarian Law

This Guide explains the terms, concepts, and rules of humanitarian law in accessible and reader-friendly alphabetical entries.

GO TO SITE
MSF Paediatric Days

The MSF Paediatric Days is an event for paediatric field staff, policy makers and academia to exchange ideas, align efforts, inspire and share frontline research to advance urgent paediatric issues of direct concern for the humanitarian field.

GO TO SITE
MSF Foundation

The MSF Foundation aims to create a fertile arena for logistics and medical knowledge-sharing to meet the needs of MSF and the humanitarian sector as a whole.

GO TO SITE
DNDi

A collaborative, patients’ needs-driven, non-profit drug research and development organisation that is developing new treatments for neglected diseases, founded in 2003 by seven organisations from around the world.

GO TO SITE
MSF Science Portal

Our digital portal dedicated to sharing the latest medical evidence from our humanitarian activities around the globe.

GO TO SITE
Noma

Noma is a preventable and treatable neglected disease, but 90 per cent of people will die within the first two weeks of infection if they do not receive treatment.

GO TO SITE
TIC

The TIC is aiming to change how MSF works to better meet the evolving needs of our patients.

GO TO SITE
Telemedicine

MSF's telemedicine hub aims to overcome geographic barriers for equitable, accessible, and quality patient care.

GO TO SITE
Sweden Innovation Unit

Launched in 2012, the MSF Sweden Innovation Unit deploys a human-centered approach for promoting a culture of innovation within MSF.

GO TO SITE
7683 Results
 
Cholera outbreak in Yemen
Yemen

Yemen: A timeline of more than three years of war

A timeline of more than three years of war Project Update - 4 Apr 2018
 
Raqqa
Syria

Raqqa - The hidden deadly threat

"Raqqa is devastated and many homes and public places were, and still are, littered with improvised explosive devices and unexploded munitions." Photo Story - 4 Apr 2018
 
Broken childhood - Demining urgently needed in Deir ez-Zor
Syria

Patient numbers double in northeast as more people return home to landmines

“These explosive devices do not choose their targets. They do not respect peace treaties or ceasefires and can stay concealed for months or years after a conflict ends.” Project Update - 3 Apr 2018
 
msf-placeholder
Tuberculosis

Breast tuberculosis in men: A systematic review

Breast tuberculosis in male is a rarely reported and poorly described condition. Public Library of Science - 3 Apr 2018
 
North Yemen: living under daily coalition airstrikes
Yemen

Pledging conference – money alone is not enough

"The pledges made today by donor countries are obviously essential, however they must be complemented by much more robust action on the ground." Statement - 3 Apr 2018
 
Damaged buildings in Diyala, Iraq
Iraq

Isolated, angry, anxious and stressed - mental health in Iraq

The psychological and emotional scars of war in Iraq are immense and thousands of people need mental health assistance. Voices from the Field - 2 Apr 2018
 
Rubber boat is waiting for a rescue
Mediterranean migration

MSF Evacuates 39 Vulnerable People From Packed Rubber Boat

Yesterday at 10.32am the search and rescue ship Aquarius along with the Libyan coast guard, were alerted by the Italian Rescue Maritime Coordination Centre (IMRCC) to a rubber boat in distress with an estimated 120 people, in international waters 23-24 nautical miles from the Libyan coast. Statement - 1 Apr 2018
 
msf-placeholder
Tuberculosis

Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis

The World Health Organization recommended two new drugs, bedaquiline (BDQ) and delamanid (DLM), for the treatment of multidrug-resistant tuberculosis (MDR-TB) in 2013 and 2014, respectively. An estimated one third of patients with MDR-TB would benefit from the inclusion of these drugs in their treatment regimens. The International Journal of Tuberculosis and Lung Disease - 1 Apr 2018
 
msf-placeholder
Tuberculosis

Tuberculosis in Visceral Leishmaniasis-Human Immunodeficiency Virus Coinfection: An Evidence Gap in Improving Patient Outcomes?

Visceral leishmaniasis (VL)-human immunodeficiency virus (HIV) coinfection remains a major problem in Ethiopia, India, and Brazil. Tuberculosis (TB), a treatable factor, could contribute to high mortality (up to 25%) in VL-HIV coinfection. However, the current evidence on the prevalence and clinical impact of TB in VL-HIV coinfection is very limited. In previous reports on routine care, TB prevalence ranged from 5.7% to 29.7%, but information on how and when TB was diagnosed was lacking.
 Open Forum Infectious Diseases - 1 Apr 2018
 
Sexual and Reproductive Health in the Community
Bangladesh

Three questions about sexual violence against Rohingya refugees

MSF teams in Bangladesh are treating survivors of sexual violence as part of their response to the Rohingya refugee crisis. To date, they have treated more than 125 people but the suspected number of cases is much higher. Midwife Aerlyn Pfeil helped set up the programme. Here, she answers questions about the challenges in treating these patients, MSF's approach, and what she will remember about the survivors she met in Bangladesh. Voices from the Field - 1 Apr 2018
Cholera intervention in South Kivu
Médecins Sans Frontières (MSF)

Independent medical humanitarian assistance

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.

Learn more